Rosenzweig-Lipson S, Barton R, Gallagher M, Edgar CJ, Maruff PT, Mohs R. HOPE4MCI trial: First trial targeting reduction of hippocampal overactivity to treat mild cognitive impairment due to Alzheimer’s disease with AGB101. Alzheimer's & Dementia, 07 December 2020 Alzheimer's & Dementia

Recommends

Please login to recommend the paper.

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

This paper appears in the following:

Therapeutics

  1. AGB101